Implantica's lead product, RefluxStop™, is a CE-marked implant for the prevention of gastroesophageal reflux that will potentially create a paradigm shift in anti-reflux treatment as supported by successful clinical trial results.

Source: https://www.prnewswire.com/news-releases/bulletin-from-the-annual-general-meeting-of-implantica-ag-301835369.html

In the ongoing study, the original three cohorts included patients with non-small cell lung cancer, EGFR wild type, gastric and gastroesophageal junction adenocarcinoma and pancreatic hepatocellular and biliary tract cancers respectively.

Source: https://seekingalpha.com/article/4651686-affimed-n-v-afmd-q3-2023-earnings-call-transcript?source=feed_all_articles

“Nausea is a symptom of gastroesophageal reflux disease (GERD), where acid builds up in the stomach and then travels to the upper part of the esophagus,” says Dr. Mudassar.

Source: https://parade.com/889608/krissybrady/why-am-i-nauseous/